Nvidia(US:NVDA) 智通财经网·2025-06-18 13:46Core Insights - SandboxAQ, an AI startup spun off from Alphabet and supported by Nvidia, has launched a large-scale synthetic dataset aimed at accelerating global drug development by simulating interactions between drug molecules and proteins [1][2] - The company has raised nearly $1 billion in funding and seeks to overcome traditional laboratory research limitations by reconstructing the underlying logic of drug screening through computational power [1] Group 1: Technology and Innovation - SandboxAQ uniquely integrates computational chemistry with artificial intelligence, utilizing Nvidia's high-performance chips to create an algorithmic platform that solves quantum mechanics equations to generate 5.2 million three-dimensional molecular structures not yet observed in reality [1][2] - The synthetic dataset significantly enhances predictive efficiency, allowing researchers to quickly identify potential candidate molecules for drug targets, which traditionally would take years to synthesize and test [2] Group 2: Market Impact and Business Model - The innovative approach is reshaping the early stages of drug development, particularly in oncology, where the time and cost of developing new drugs can be drastically reduced from years to weeks [2] - While the synthetic dataset is freely available for academic use, the company commercializes the AI predictive models trained on this data, creating a hybrid model of "data open-source + model charging" that fosters foundational research while establishing a sustainable technological barrier [2]